AB1047 FLARE PREVENTION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS TREATED WITH BELIMUMAB VERSUS STANDARD OF CARE: A PROPENSITY SCORE-MATCHED COMPARATIVE, CASE-CONTROL STUDY - Rúa-Figueroa, Í.; Altabás González, I.; Roberts, K.; Casafont-Solé, I.; Hernández, A.; De la Rubia Navarro, M.; Galindo, M.; Salman-Monte, T. C.; Vidal-Montal, P.; Garrote-Corral, S.; Blázquez, M. Á.; Piqueras Garcia, M. M.; et al. (Annals of the rheumatic diseases, 2024)
Keywords: biological DMARD; BLyS protein; Clinical trials; Glucocorticoids; Hydroxychloroquine; Lupus; Monoclonal antibodies; Nephritis; Observational studies/ registry; Prednisone; Proteinuria; Rheumatology; Risk factors; Scientific Abstracts; Standard of care; Statistical analysis; Systemic lupus erythematosus; biological DMARD; Observational studies/ registry